ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
87 |
18K |
3 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
87
|
18K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
87 |
18K |
13 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
87
|
18K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
87 |
18K |
15 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
87
|
18K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
87 |
18K |
30 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
87
|
18K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
87 |
18K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
87
|
18K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
87 |
18K |
20 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
87
|
18K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
87 |
18K |
22 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
87
|
18K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
Peeteepoo
|
104 |
17K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
104
|
17K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
Peeteepoo
|
104 |
17K |
12 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
104
|
17K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
19 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
8 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
5 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Dr Rebecca McQualter appointed COO
|
|
Peeteepoo
|
13 |
3.5K |
5 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
13
|
3.5K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
10 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
15 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
7 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PAA TOP HOLDERS MOVEMENTS AS AT 30 APRIL 2024
|
|
Peeteepoo
|
5 |
1.4K |
7 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
5
|
1.4K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PAA TOP HOLDERS MOVEMENTS AS AT 30 APRIL 2024
|
|
Peeteepoo
|
5 |
1.4K |
4 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
5
|
1.4K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
5 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
7 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
10 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
14 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
12 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
Peeteepoo
|
104 |
17K |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
104
|
17K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
16 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
64K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
11 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
64K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
8 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
64K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
25 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
64K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
8 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
35 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
261
|
64K
|
35
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
25 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
261
|
64K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
64K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Peeteepoo
|
31 |
8.8K |
16 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
31
|
8.8K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
20 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
64K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
64K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
64K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
13 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
64K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
25 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
37 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
37
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
10 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
64K |
32 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
32
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
20 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
34 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
34
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
327K |
13 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
13
|
|